| Reckitt Benckiser (Switzerland) AG - Gaviscon Liquid Mint, Suspension zum Einnehmen in Flaschen | | 62887 | | 01 | | Gaviscon Liquid Mint | | Suspension zum Einnehmen in Flaschen | | A02AX | | Antacids, Other Combinations | | 05.06.2013 | | |
| | Composition | | natrii alginas 500 mg, natrii hydrogenocarbonas 267 mg, calcii carbonas 160 mg, aromatica, saccharinum natricum, conserv.: E 216, E 218, excipiens ad suspensionem pro dosi 10 ml. | | Packungsbestandteile | | Suspension zum Einnehmen in Flaschen | | | | | | Active Agent | Dose |
|---|
| Calcium Carbonate | 160 mg | | Sodium Alginate | 500 mg | | Sodium Hydrogen Carbonate | 267 mg |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
